Asset

Total 158, page 1/8

No. Organization Therapeutic Area Product Type Title
158 Max-Planck Innovation Oncology Small molecule Overcoming Disease Persistence in Myeloproliferative Neoplasms (MPN) through Combinatorial Inhibitor Treatment
157 SRI International Oncology Peptide An Optimized Peptide for Targeting of Epithelial Derived Tumors
156 Yale University Oncology Small molecule Novel Small Molecule Inhibitor for Treatment of PARP Inhibitor-resistant Ovarian Cancer
155 Yale University Oncology Small molecule Treatment of KRAS-Variant Cancers with Serotonin Transporter Inhibitors
154 Wisconsin Alumni Research Foundation Fibrosis Peptide Compositions and Methods for the Inhibition of Fibrosis
153 Wisconsin Alumni Research Foundation Genetic disorders Gene therapy Gene Correction of Pompe Disease and Other Autosomal Recessive Disorders via CRISPR and other RNA-Guided Nucleases
152 Wisconsin Alumni Research Foundation Oncology Cell therapy Nonviral Generation of Genome-Edited CAR T Cells
151 Wisconsin Alumni Research Foundation Inflammatory disease Protein Method to Inhibit Neutrophil Recruitment to Damaged Tissue Using Myeloid-Derived Growth Factor
150 University of Pennsylvania Musculoskeletal disease Nucleotide Site-Blocking Oligos (SBO) Upregulate Utrophin for Treatment of Duchenne Muscular Dystrophy (DMD)
149 University of Pennsylvania Inflammatory disease Nanoparticle Novel Nanoparticle Composition Targeting Marginated Leukocytes
148 University of Pennsylvania Oncology Cell therapy Adoptive T Cell Therapy for Cancer using Mutant KRAS-specific T Cell Receptors for T Cell Engineering
147 University of Florida Oncology Small molecule Anticancer Agents for Triple-Negative Breast Cancers
146 University of Florida CNS disease Nanoparticle Antigen-Specific Tolerizing Treatment for Multiple Sclerosis
145 University of Florida Oncology Gene therapy AAV Vectors for Direct Delivery of shRNA into Islet Cells to Treat Pancreatic Cancer
144 University of Florida Oncology Antibody Hyal2/Hyal1-Expressing Myeloid Cells as a Target for Cancer Immunotherapy
143 University of Florida Oncology Small molecule Small Molecule Inhibitors Against Cancer-Associated Protein
142 University of Colorado Oncology Small molecule Novel Inhibitors of PARP1/2
141 University of Chicago Immunology Peptide FOXP3 Stapled Peptides to Deactivate Regulatory T Cells
140 University of Central Florida Genitourinary disease Small molecule Spermine Prodrugs for Treating Low Spermine Disorders
139 University of California - Los Angeles Inflammatory disease Nanoparticle Liver-Targeting Tolerogenic Nanoparticles

TOP